MAIT cell activation augments adenovirus vector vaccine immunogenicity

Originally published on Science. 2021 Jan 29;371(6528):521-526. doi:10.1126/science.aax8819.PMID: 33510029.

  • Capone S, Brown A, Hartnell F, Sorbo MD, Traboni C, Vassilev V, Colloca S, Nicosia A, Cortese R, Folgori A, Klenerman P, Barnes E, Swadling L.

Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans.
NPJ Vaccines. 2020 Oct 12; 5:94. doi: 10.1038/s41541-020-00240-0. eCollection 2020.

MAIT cell activation augments adenovirus vector vaccine immunogenicity

Originally published on Science. 2021 Jan 29;371(6528):521-526. doi:10.1126/science.aax8819.PMID: 33510029.

  • Capone S, Brown A, Hartnell F, Sorbo MD, Traboni C, Vassilev V, Colloca S, Nicosia A, Cortese R, Folgori A, Klenerman P, Barnes E, Swadling L.

Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans.
NPJ Vaccines. 2020 Oct 12; 5:94. doi: 10.1038/s41541-020-00240-0. eCollection 2020.